Bertin Bioreagent

anti-TAF6, mAb (2G7)

As low as CHF 664.00
In stock
Only %1 left
BRT-G01086-R100100 µlCHF 664.00
 
More Information
Product Details
Synonyms Transcription Initiation Factor TFIID Subunit 6; TATA-Box Binding Protein-Associated Factor 6; TAFII70; TAFII80; RNA Polymerase II TBP-associated Factor Subunit E
Product Type Monoclonal Antibody
Properties
Clone 2G7
Isotype Mouse IgG1κ
Source/Host Mouse
Immunogen/Antigen Synthetic peptide.
Application ELISA, Western Blot (natural and recombinant proteines), Immunocytofluorescence. Recommended dilutions: 1/500-1/1000.
Specificity Recognizes human and mouse TAF6.
Formulation Liquid. Does not contain any preservative.
Other Product Data

Click here for Original Manufacturer Product Datasheet
Our product description may differ slightly from the original manufacturers product datasheet.

Declaration Manufactured by Bertin Bioreagent
Shipping and Handling
Shipping BLUE ICE
Long Term Storage -20°C
Handling Advice Avoid freeze/thaw cycles.
Use/Stability Stable for at least 3 years after receipt when stored at -20°C.
Documents
Product Specification Sheet
Datasheet Download PDF
Description
TAF6 is a core subunit of the TFIID complex, which is essential for RNA polymerase II-dependent transcription initiation. It plays a significant role in gene expression regulation by participating in the formation and stability of the TFIID complex. TAF6 is an important subunit of the TFIID complex, a multi-protein complex involved in the recognition of core promoter elements (such as the TATA box) and the recruitment of RNA polymerase II to initiate transcription. TAF6 works closely with other TAFs (like TAF1, TAF4, TAF5, and TAF12) to stabilize the complex and help in the assembly of the transcription machinery. TAF6 may contribute to chromatin remodeling, facilitating accessibility of DNA to the transcription machinery. Disruptions in TAF6 function may contribute to tumorigenesis and cancer progression, especially through the dysregulation of genes involved in cell cycle control and apoptosis. Mutations or altered expression of TAF6 could potentially contribute to neurological diseases that involve defects in gene expression regulation.
© 2017 Adipogen Life Sciences. Pictures: © 2012 Martin Oeggerli. All Rights Reserved.